Obsessive-Compulsive Disorder (OCD)
Obsessive-compulsive disorder (OCD) is a common, chronic, and long-lasting disorder characterized by uncontrollable, reoccurring thoughts (obsessions) and/or behaviors (compulsions) that people feel the urge to repeat over and over. Symptoms can fluctuate over time, and people with OCD may try to help themselves by avoiding situations that trigger their obsessions. OCD is a common disorder that affects adults, adolescents, and children, and most people with the disorder are diagnosed by early adulthood. Learn more about obsessive-compulsive disorder (OCD).
Featured Studies
Featured studies include only those currently recruiting participants. Studies with the most recent start date appear first.
Cognitive Control Targets for the Treatment of Obsessive Compulsive Disorder in Young Children
Study Type: INTERVENTIONAL
Start Date: June 27, 2024
Eligibility: 8 Years to 12 Years, f
Location(s): Columbia University Irving Medical Center, New York, New York, United States
This study aims to examine the effects of a game-like program called cognitive control training (CT) for children with obsessive compulsive disorder (OCD). Children enrolled in this study will receive 4 weeks of the at-home computerized cognitive training program (AKL-T01) delivered on iPad (25 minutes/day, 5 days/week). Styled as a child-friendly video game, AKL-T01 CT taps focused attention, response inhibition, and working memory using a series of games to engage cognitive control processes. Children will complete the NIH Toolbox prior to, mid (2-weeks), and post-CT (4-weeks). Participants will complete MRI scans pre- and post-CT and then be offered a 12-week course of gold-standard Cognitive behavioral therapy with exposure and response prevention (or community referrals) after CT. The long-term goal of this study is to test how this CT intervention may enhance cognitive control capacity to reduce symptoms and improve response to cognitive behavioral therapy with exposure and response prevention in children with OCD.
Examining Mu Opioid Mechanisms of Ketamine's Rapid Effects in OCD (MKET2)
Study Type: INTERVENTIONAL
Start Date: February 24, 2024
Eligibility: 18 Years to 65 Years, t
Location(s): Department of Psychiatry & Behavioral Sciences, Stanford, California, United States
The purpose of this study is to understand how ketamine works in the brain to bring about a reduction in OCD symptoms.
A Precision Medicine Approach to Target Engagement for Emotion Regulation
Study Type: INTERVENTIONAL
Start Date: September 29, 2023
Eligibility: 18 Years to , f
Location(s): University of Kentucky, Lexington, Kentucky, United States
The proposed study is designed to first test whether teaching people personalized or standardized emotion regulation skills leads to greater decreases in daily negative emotion intensity. Second, using data from an initial sample, the investigators will prospectively assign an independent sample of participants to receive their predicted optimal or non-optimal skills to determine if it is feasible and efficacious to match participants to the most appropriate training condition. Results of these studies may identify the mechanisms by which emotion regulation interventions impact emotional functioning and allow for the development of personalized, evidence-based, and scalable emotion regulation interventions.
Neurostimulation Versus Therapy for Problems With Emotions
Study Type: INTERVENTIONAL
Start Date: May 15, 2023
Eligibility: 18 Years to 55 Years, f
Location(s): Duke University Medical Center, Durham, North Carolina, United States
The primary goal of this clinical trial is to evaluate the unique neural and behavioral effects of a one-session training combining emotion regulation skills training, with excitatory repetitive transcranial magnetic stimulation (rTMS) over the dorsolateral prefrontal cortex (dlPFC). The secondary aim is to identify key changes in the emotion regulation neural network following the combined intervention versus each of the components alone. The third aim is to explore personalized biomarkers for response to emotion regulation training.
Participants will undergo brain imaging while engaging in an emotional regulation task. Participants will be randomly assigned to learn one of two emotion regulation skills. Participants will be reminded of recent stressors and will undergo different types of neurostimulation, targeted using fMRI (functional MRI) results. Participants who may practice their emotion regulation skills during neurostimulation in a one-time session. Following this training, participants will undergo another fMRI and an exit interview to assess for immediate neural and behavioral changes. Measures of emotion regulation will be assessed at a one week and a one month follow up visit.
CO2 Reactivity as a Biomarker of Non-Response to Exposure-Based Therapy
Study Type: INTERVENTIONAL
Start Date: November 2, 2022
Eligibility: 18 Years to 70 Years, f
Location(s): Boston University, Boston, Massachusetts, United States; The University of Texas at Austin, Austin, Texas, United States
Anxiety-, obsessive-compulsive and trauma- and stressor-related disorders reflect a significant public health problem. This study is designed to evaluate the predictive power of a novel biomarker based on a CO2 challenge, thus addressing the central question "can this easy-to-administer assay aid clinicians in deciding whether or not to initiate exposure-based therapy?"
Computerized Intervention Targeting the Error-Related Negativity and Balance N1 in Anxious Children
Study Type: INTERVENTIONAL
Start Date: October 12, 2022
Eligibility: 9 Years to 12 Years, t
Location(s): FSU Psychology Building, Tallahassee, Florida, United States
Anxiety disorders are the most common form of psychopathology, and frequently begin in childhood, resulting in lifelong impairment. Increased brain activity after making mistakes, as reflected by the error-related negativity (ERN), is observed in people with anxiety disorders, even before disorder onset. The ERN is therefore of great interest as a potentially modifiable risk factor for anxiety. However, methodological issues can make the ERN difficult to measure.
Increased brain activity in response to a balance disturbance, as reflected by the balance N1, resembles the ERN, but does not share its methodological issues. The investigators' preliminary data demonstrate that the balance N1 and the ERN are associated in amplitude in adults, suggesting they may depend on the same brain processes. The balance N1 has never been investigated in individuals with anxiety disorders, but it increases in amplitude within individuals under anxiety-inducing environmental contexts. Further, balance and anxiety are related in terms of brain anatomy, daily behavior, disorder presentation, and response to treatment.
The present investigation will measure the ERN and the balance N1 in children (ages 9-12) with anxiety disorders, and further, how these brain activity measures change in response to a brief, 45-minute, computerized psychosocial intervention that was developed to reduce reactivity to errors, and has been shown to reduce the ERN. The investigators will recruit approximately 80 children with anxiety disorders, half of whom will be randomly assigned to the active intervention condition. The other half will be assigned to an active control condition, consisting of a different 45-minute computerized presentation. Participants assigned to the control condition can access the computerized intervention after participation in the study.
The purpose of this investigation is to test the hypothesis that the balance N1 and the ERN will be reduced to a similar extent after the intervention, to demonstrate that these brain responses arise from shared brain processes. Transfer of the effect of the psycho-social intervention to the balance N1 would provide insight into prior work demonstrating that balance training can alleviate anxiety in young children, and well-documented benefits of psychotherapy to balance disorders. Collectively, these data may guide the development of multidisciplinary interventions for the prevention and treatment of anxiety disorders in children.
Developing Brain, Impulsivity and Compulsivity
Study Type: OBSERVATIONAL
Start Date: September 30, 2022
Eligibility: 6 Years to 80 Years, f
Location(s): National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Background:
Impulsivity is acting 'without thinking.' Compulsivity is being overly inflexible. People vary in how impulsive or compulsive they are. Extreme versions of these behaviors play a role in mental disorders. Researchers want to study changes in the brain to learn more about these behaviors. Differences in genes may also play a role.
Objective:
To learn about genetic \& brain features that explain why levels of impulsivity and compulsivity vary across people.
Eligibility:
People ages 6 - 80
Design:
Participants will be screened with a medical history and medical record review.
Participants will talk about their mental and behavioral development. They may discuss topics like drug use and sexual activity. They will complete surveys about their compulsivity and impulsivity. Parents of child participants may also complete these surveys.
Participants may take memory, attention, and thinking tests. They may give blood or saliva samples for gene studies.
Participants may have a magnetic resonance imaging scan. It will take pictures of their brain. The scanner is shaped like a cylinder. Participants will lie on a table that slides in and out of the scanner. A coil will be placed over their head. They will lie still, watch a movie, and play a game.
Participants may have a magnetoencephalography scan. It records brain activity. Participants will sit in a room. A "cone" of magnetic field detectors will be lowered around their head. They will rest and play a game.
Participants may ask family members to join the study.
Participants under age 25 may repeat these tests every 1-2 years until they turn 25 or until the study ends. For those over age 25, participation will last less than 1 month.
Motivational Interviewing to Enhance Behavioral Change in Older Adults With Hoarding Disorder
Study Type: INTERVENTIONAL
Start Date: June 1, 2022
Eligibility: 60 Years to , f
Location(s): Mississippi State University, Starkville, Mississippi, United States
This study will compare two behavioral interventions for hoarding disorder in older adults.
Theta Burst Stimulation Plus Habit Override Training for Compulsive Behaviors
Study Type: INTERVENTIONAL
Start Date: December 28, 2020
Eligibility: 18 Years to 60 Years, f
Location(s): Western Psychiatric Institute and Clinic, Pittsburgh, Pennsylvania, United States
This project seeks to identify causal neural mechanisms underlying unwanted, repetitive behaviors (compulsions). Using non-invasive brain stimulation coupled with practice in a computer task, we will modulate activity in a target brain region and measure effects on compulsive behaviors and related measures. This work could ultimately lead to the ability to treat compulsions more effectively by targeting the regions of the brain that can help or hinder attempts to overcome compulsions.
Brain Network Changes Accompanying and Predicting Responses to Pharmacotherapy in OCD
Study Type: INTERVENTIONAL
Start Date: October 14, 2019
Eligibility: 18 Years to 65 Years, t
Location(s): Yale OCD Research Clinic - CMHC/CNRU, 34 Park ST, New Haven, Connecticut, United States
The proposed randomized, double-blind research study will use functional magnetic resonance neuroimaging using state-of-the-art HCP acquisition protocols and analytic pipelines, to identify predictors and correlates of response to an accepted first-line pharmacological treatment for obsessive-compulsive disorder.
Physiological Brain Atlas Development
Study Type: OBSERVATIONAL
Start Date: August 31, 2006
Eligibility: 6 Years to 90 Years, f
Location(s): Vanderbilt Univeristy, Nashville, Tennessee, United States
The NIH grant has funded the development of a physiological brain atlas registry that will allow us to significantly improve the data collectioin and use of physiological data into a normalized brain volume. This initially was used to improve DBS implants for Parkinson's Disease, Dystonia, Essential Tremor, and OCD, but now includes data acquired during all stereotactic brain procedures.